Abstract
Bacterial antimicrobials resistance is a public health concern worldwide, greatly compromising therapeutic options. Bacteria from the ESKAPE-E group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp. and Escherichia coli) represent one of the greatest clinical risks, especially for hospitalized patients, …